Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to -$1.27.

  • Avidity Biosciences' EPS (Basic) fell 9538.46% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.19, marking a year-over-year decrease of 4498.27%. This contributed to the annual value of -$2.89 for FY2024, which is 81.6% up from last year.
  • Avidity Biosciences' EPS (Basic) amounted to -$1.27 in Q3 2025, which was down 9538.46% from -$1.21 recorded in Q2 2025.
  • Avidity Biosciences' 5-year EPS (Basic) high stood at -$0.64 for Q1 2021, and its period low was -$1.27 during Q3 2025.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.79 (2024), whereas its average is -$0.82.
  • Data for Avidity Biosciences' EPS (Basic) shows a peak YoY increase of 7009.35% (in 2021) and a maximum YoY decrease of 11935.48% (in 2021) over the last 5 years.
  • Over the past 5 years, Avidity Biosciences' EPS (Basic) (Quarter) stood at -$0.84 in 2021, then dropped by 5.95% to -$0.89 in 2022, then grew by 10.11% to -$0.8 in 2023, then fell by 14.78% to -$0.92 in 2024, then crashed by 38.31% to -$1.27 in 2025.
  • Its last three reported values are -$1.27 in Q3 2025, -$1.21 for Q2 2025, and -$0.9 during Q1 2025.